Print

Print


Thank you for all the info on NADH.  I have one quick qusetion (it may=20
seem simplistic, but it's puzzling me):  How/Are nicotine, nicotinamide, an=
d=20
NADH related?

Beth Leslie



On Thu, 23 Jan 1997, Forrests Mom wrote:

> NADH FAQ's
>=20
>=20
> Q. What is NADH?
>=20
> A. NADH is the abbreviation for the reduced form of
> nicotinamide-adenine-dinucleotide. This reduced form contains high energy
> hydrogen (the H in NADH) that provides energy to the cell. NADH occurs in
> all living cells and plays a central role in the energy production of the
> cells(1). The more energy a cell needs, the more NADH it needs. For examp=
le,
> muscle cells and brain cells contain about 50 micrograms NADH per gram
> tissue, heart cells 90 micrograms, red blood cells 4 micrograms(2). In ot=
her
> words, if you supply NADH to the body, it acts as an energy supplement,
> which provides the organism with additional energy.=20
>=20
> NADH occurs naturally in the muscle tissue of many animals, such as fish,
> poultry and cattle that are part of our diet (3).=20
>=20
> Q. What does NADH do in the body?
>=20
> A. NADH is the first and most energetic component in the central energy
> producing mechanism in our cells(4). Thus it plays a crucial role in
> supplying our cells with energy.=20
>=20
> In addition NADH supplies the energy for the production of important
> compounds in our cells. NADH increases the production of adrenaline and
> dopamine, particularly in the brain(5, 6) It improves aspects of brain an=
d
> central nervous system function which are related to the activity of
> dopamine and adrenaline.=20
>=20
> Q. How was NADH discovered?
>=20
> A. NADH was discovered in 1934 by Kaplan, an American scientist who found
> that it plays an essential role in the energy production of cells(7).=20
>=20
> Q. Who should take NADH?
>=20
> A. Anyone that that wants to support the function of the central nervous
> system and the energy production in all cells.=20
>=20
> Q. Who is Georg Birkmayer?
>=20
> A. Professor Georg Birkmayer, MD, Ph.D., is the director of a clinical
> laboratory in Vienna, Austria as well as a world renowned biochemical
> researcher. He is associated with the University of Vienna and is a visit=
ing
> professor at the University of Beijing, China. He is the general secretar=
y
> of the International Academy of Tumor Marker Oncology. In addition to bei=
ng
> a practicing physician, he is the author of more than 100 scientific arti=
cles.=20
>=20
> References:
>=20
> 1. Lehninger, A.L. (1970): Biochemistry, Worth Publisher Inc. 1970.=20
>=20
> 2. Klingenberg M. (1960): Zur Bedeutung der freien Nucleotide. 11.Moosbac=
her
> Kolloquium Springer Verlag p. 82-114=20
>=20
> 3. Sauberlich H.E. (1987): Nutritional Aspects of Pyridine Nucleotides, i=
n
> Dolphin D, Poulson R., Avramovic O. (editors): Pyridine Nucleotide Coenzy=
mes
> (Part B), John Wiley & Sons, Inc. 1987, p. 599-626=20
>=20
> 4. Alberts B, et al (1983): Molecular Biology of the Cell, Garland
> Publishing, 1983, p. 491-495.=20
>=20
> 5. Vrecko K., Birkmayer JGD and Krainz J. (1993): Stimulation of dopamine
> biosynthesis in cultured PC12 phaeochromocytoma cells by the coenzyme
> nicotinamide adenine dinucleotide (NADH), J. Neur. Trans. 5:147-156=20
>=20
> 6. Gardier M. (1994) Study Report to Labor Birkmayer, Department
> Pharmacology, University Paris Sud.=20
>=20
> 7. Kaplan N.O. (1960) in Boyer PD, Lardy H. and Myrbaeck K.: The Enzymes
> Vol. 3, Ac Press New York p. 156-172=20
>=20
> Colloidal NaDH, Order Form=20
>=20
> Home Page=20
> ------------------------------------------------------------------------
>=20
>=20
> Copyright =A91996 by Chronic Wellness International=99=20
>=20
> Last Updated 11/03/96=20
>=20